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We assessed the undercount of meningiomas in a population-based cancer registry. A comprehensive material was formed by
compiling hospital sources with the Finnish Cancer Registry database. The completeness of each source ranged 62–69%. The
corrected age-standardised meningioma incidence was 2.9/100000 for men and 13.0/100000 for women, a third higher than the
cancer registry figures.
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Meningiomas are typically benign tumours, arising from the
meninges of the brain (in at least 90% of the cases) and the spinal
cord (Berger and Prados, 2004). They are benign in more than 90%
of the cases, borderline/atypical in approximately 5% of the cases
and malignant in less than 5% of the cases (Claus et al, 2005).
Meningiomas are the most frequently reported intracranial
tumours, accounting for approximately one-fourth of all reported
primary brain neoplasms (Surawicz et al, 1999; Claus et al, 2005).
The age-standardised (world population) national incidence
rates of meningiomas reported by the Finnish Cancer Registry
(FCR) are 1.6 per 100000 for men and 5.5 for women in 2001. The
corresponding rates in the Nordic countries are 1.9 and 4.5 per
100000 person-years, respectively (Klaeboe et al, 2005). In the
United States, the incidence rates with similar age-standardisation
estimated from figures provided by the Central Brain Tumor
Registry of the United States were 1.8 for men and 4.2 per 100000
for women in 2006. Incidence of meningiomas varies depending on
whether autopsies are included or not (Haddad et al, 2003).
Increasing incidence rates of meningiomas have been reported
from several industrialised countries since the early 1980’s
(Christensen et al, 2003; Klaeboe et al, 2005), and the increase is
most pronounced in older age groups (Maurice-Williams and
Kitchen, 1993). The increase among the elderly can be explained by
several factors. Indolent cases unrelated to the symptom for which
the examination was conducted (eg, post-traumatic computerised
tomography (CT)) are likely to be most common in older age
groups. Also, introduction of new radiological techniques has
allowed more non-invasive examinations for inoperable patients.
As meningiomas are benign in at least 9 out of 10 cases, they are
not covered by most cancer registries. Nevertheless, in Finland, as
in other Nordic countries, all physicians, pathologic laboratories
and hospitals are obliged to report all tumours of the central
nervous system, both malignant and benign, to the cancer registry.
The nationwide, population-based FCR has a practically
complete coverage of solid cancer cases in Finland (Teppo et al,
1994). However, the registration of benign tumours of the central
nervous system is not as complete as that of malignant neoplasms.
Particularly, cases that are not treated surgically and lack
histological confirmation are likely to be under-reported.
The aim of our study was to quantify undercount in the cancer
registry and provide corrected estimates of meningioma incidence.
MATERIALS AND METHODS
The meningioma cases were identified from Pirkanmaa Hospital
District in Finland, which is the catchment area for Tampere
University Hospital with a population of 447051 in 2000. The study
period was from November 2000 through June 2001 (eight months).
The cases were identified from four clinical data sources within
Tampere University Hospital: (1) neurosurgical clinic; (2) pathology
database; (3) hospital discharge database and (4) autopsy database.
The department of neurosurgery provided a list of cases seen by
their neurosurgeons, including operated and non-operated cases,
outpatients and consultations on patients at other units. The
pathology database included all cases diagnosed at the pathology
unit (including biopsy). An autopsy database with diagnoses made
in post-mortem examinations was also used. The hospital
discharge database covers the major diagnoses of all in-patients
admitted to the hospital.
The cases based on these clinical data sources and verified from
the hospital records were compared with the case list of
meningioma patients retrieved from the FCR. Information
extracted from each source included the national unique personal
identification number, place of residence, diagnosis, date of
diagnosis and method of confirmation. Only residents in
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ymunicipalities within the Pirkanmaa Hospital District were
included. Only incident intracranial meningioma cases from
November 2000 till June 2001 were included in this study.
The permission to obtain data from the FCR was granted by the
National Research and Development Centre for Welfare and
Health (STAKES). The study involved no contact with patients and
was, therefore, exempt from a written informed consent in
accordance with the Finnish regulations.
The world standard population was used in the age-standardisa-
tion (Segi, 1960). The incidence rates were calculated in 5-year age
groups (even though presented in 10-year age groups in the
tables). Confidence intervals (CIs) for the incidence rates were
calculated assuming that the observed numbers of meningioma
cases followed a Poisson distribution (Breslow and Day, 1987). CI
for cancer registry coverage was estimated applying the general
formula for the CI of a proportion.
RESULTS
Altogether, 42 incident intracranial meningioma patients were
identified. The data sources from different hospitals identified a
total of 39 patients and the FCR had information on 3 additional
patients.
Altogether, the FCR covered 29 intracranial meningiomas
during the study period. Of those, 27 fulfilled the inclusion
criteria, whereas 2 were not incident cases, but recurrences.
Twenty-nine patients with newly diagnosed meningiomas were
identified from the records of the neurosurgical department of
Tampere University Hospital. Eighteen patients were operated on
and 11 were treated conservatively. Twenty-six patients were
identified from the Tampere University Hospital discharge
database. Twenty-six patients fulfilling our definitions were found
from the pathology database. Two of them were incidental cases
detected in the 210 autopsies performed during the study period
(Table 1).
Of the clinically recorded 39 patients, the FCR had registered 24.
Of the 15 missing cases, 2 were found in the hospital discharge
register only, based on radiological confirmation. No clinical or
pathological cancer registry notifications were received at the FCR
for 13 patients; 9 with a clinical diagnosis and 4 with a pathological
verification.
The FCR had information on three patients not found in the
clinical records: one was a histologically verified case and two were
suspected meningiomas based on radiological findings only. All
three were in-patients at the Tampere University Hospital, but
without a discharge diagnosis of meningioma.
The cancer registry covered 27 of the 42 meningiomas (64%).
The completeness of the FCR was 69% (95% CI, 55–83) of the 42
cases fulfilling the criteria, including the 2 recurrent cases.
Of the 42 cases, only 11 (26%) were found in all the four data
sources (autopsy database excluded). Only 13 (31%), including the
previously mentioned 11 were covered by the three most
comprehensive sources of information: neurosurgery department,
hospital discharge database and FCR (Figure 1).
Diagnoses were histologically confirmed in 28 (67%) cases and
based only on radiological finding (CT and/or MRI) in 14 (33%)
cases. Under-registration was most common in cases aged 80 years
and older (27%), as well as cases confirmed only radiologically
(29%) (Table 1).
The age-standardised incidence rate of the cases from the FCR
was 2.2 per 100000 (95% CI, 0.3–4.1) for men and 9.6 (95% CI,
5.6–13.6) for women. The corresponding incidence rates for the
best estimates were 2.9 per 100000 person-years (95% CI, 0.7–5.0)
for men, and 13.0 (95% CI, 8.7–17.3) for women.
DISCUSSION
None of the five sources including the cancer registry had a
comprehensive coverage of meningioma cases. Completeness of
the cancer registry was approximately two-thirds of all cases. The
corrected incidence rates were a third higher than those reported
by the cancer registry.
In our study, the corrected age-standardised incidence rates
were 2.9 per 100000 person-years for men, and 13.0 for women
compared with 2.2 per 100000 for men and 9.6 for women based
on cancer registry data alone. The CIs (95%) for the incidence rates
did, however, overlap, indicating that the estimates are compatible
with each other. The study was limited by the small number of
meningiomas. Nevertheless, bias such as under-registration is
evaluated based on point estimates, not statistical significance.
Despite this limitation, the study succeeded in identifying
Table 1 Number of meningioma cases by gender, age, hospital sources
and diagnostic confirmation found and missing in the Finnish Cancer
Registry
Finnish cancer registry
Yes No Total
Gender
Male 5 2 7
Female 22 13 35
Age (years)
15–49 6 1 7
50–59 5 2 7
60–69 8 4 12
70–79 4 1 5
80– 3 8 11
Hospital source
Pathology 22 4 26
Neurosurgery 17 12 29
Hospital discharge registry 19 7 26
Diagnostic confirmation
Radiological 4 10 14
Microscopic
a 23 5 28
aWith or without radiological support for the diagnosis.
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4
13
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Figure 1 The numbers of meningioma cases from Pirkanmaa Hospital
District in the Finnish Cancer Registry, Tampere University Hospital
discharge registry and neurosurgical department patient list, November
2000 – June 2001. The area reflects the number of cases in each source
and their overlap.
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meningioma incidence.
There are several reasons for meningiomas not being notified to
the FCR, such as asymptomatic meningiomas being followed
clinically. In addition, incidental meningiomas, detected at autopsy
may not be reported. However, only two meningiomas were found
at autopsy in our study. This is less than anticipated, as the
proportion of meningiomas in autopsies has been estimated to be
as high as a quarter (Klaeboe et al, 2005). Also, incidental
meningiomas were found in almost 1% of asymptomatic
volunteers in a recent study (Vernooij et al, 2007).
Our results indicate that the incidence of meningiomas is
considerably underestimated. We were able to obtain corrected
incidence rates, which provide a more valid indication of the
occurrence and disease burden than those based on a single data
source. The findings also provide guidance for the conduct of not
only occurrence studies, but also etiologic and prognostic studies,
as they emphasise the need for case ascertainment and recruitment
from several sources.
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